About: http://data.cimple.eu/news-article/dc1ec36334957d198e38525c469d2c5bcf93610f23d4d563d5ee426c

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/dc1ec36334957d198e38525c469d2c5bcf93610f23d4d563d5ee426c Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Novartis agreed to pay around $336 million to settle US charges connected to bribery schemes aimed at increasing sales of its pharmaceutical products, US authorities announced Thursday. Novartis Greece, a unit of the Swiss drug giant, admitted to financing travel of employees of state-owned hospitals to the US between 2012 and 2015 "as a means to bribe these officials," the Justice Department said. Novartis Greece also admitted that in 2009 and 2010 it funneled money to health care providers as part of an epidemiological study that was "used as a vehicle" for improper payments to increase sales of drugs, the agency said. The Justice Department case also concerned Alcon, which was owned by Novartis at the time, and admitted to falsifying records to conceal bribes in Vietnam. To settle these charges brought under the Foreign Corrupt Practices Act (FCPA), Novartis agreed to pay criminal fines of $225 million and enter into a deferred prosecution agreement. Alcon also agreed to pay $8.9 million to settle their case, the Justice Department said. "Novartis AG's subsidiaries profited from bribes that induced medical professionals, hospitals and clinics to prescribe Novartis-branded pharmaceuticals and use Alcon surgical products, and they falsified their books and records to conceal those bribes," said US Assistant Attorney General Brian Benczkowski. In a parallel action, Switzerland-based Novartis agreed to pay $112 million to settle a civil case brought by the US Securities and Exchange Commission in which company affiliates were accused of violating recordkeeping and internal control requirements in Greece, Vietnam, South Korea and China. Novartis General Counsel Shannon Thyme Klinger said the company has now closed all outstanding FCPA probes. "Today's settlements represent another milestone in our commitment to resolving legacy compliance issues and ensuring that Novartis truly lives its values," Klinger said. jmb/cs
schema:headline	Novartis to pay $336 mn in US settlements on bribes
schema:mentions	Friedrich Maximilian Klinger Epidemiology Novartis Bribery Medication United States Department of Justice Greece Vietnam Switzerland South Korea General officer China Alcon Internal control Brian Benczkowski Foreign Corrupt Practices Act Deferred prosecution Shannon Airport United States Assistant Attorney General
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-06-25 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	88 (xsd:integer)

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software